These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2642778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients.
    Henny FC, Kleinbloesem CH, Moolenaar AJ, Paul LC, Breimer DD, van Es LA.
    Transplantation; 1985 Sep; 40(3):261-5. PubMed ID: 3898491
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients.
    Rosano TG, Freed BM, Cerilli J, Lempert N.
    Transplantation; 1986 Sep; 42(3):262-7. PubMed ID: 2944258
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
    Sommer BG, Sing DE, Henry ML, Ferguson RM, Orosz CG.
    Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
    [Abstract] [Full Text] [Related]

  • 8. Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine.
    Kahan BD, Kramer WG, Wideman CA, Frazier OH, Lorber MI, Williams C, Flechner SM, Cooley DA, Van Buren CT.
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):115-9. PubMed ID: 3538563
    [Abstract] [Full Text] [Related]

  • 9. Excretion of cyclosporine and its metabolites in human bile.
    Burckart GJ, Starzl TE, Venkataramanan R, Hashim H, Wong L, Wang P, Makowka L, Zeevi A, Ptachcinski RJ, Knapp JE.
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):46-9. PubMed ID: 3538573
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K, Kirchner GI, Rupprecht L, Gruber M, Birnbaum DE, Schmid FX, Preuner JG.
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine metabolite disposition after oral administration in pretransplant end-stage renal disease patients.
    Alexander DP, Horning L, Bowers LD.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):499-508. PubMed ID: 3284097
    [Abstract] [Full Text] [Related]

  • 18. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
    Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ.
    Clin Transplant; 1998 Dec; 12(6):553-6. PubMed ID: 9850449
    [Abstract] [Full Text] [Related]

  • 19. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.
    Falck P, Vethe NT, Asberg A, Midtvedt K, Bergan S, Reubsaet JL, Holdaas H.
    Nephrol Dial Transplant; 2008 Mar; 23(3):1048-53. PubMed ID: 17956893
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.